Distribution of HLA-B27 and its alleles in patients with reactive arthritis and with ankylosing spondylitis in Tunisia

Rheumatol Int. 2009 Aug;29(10):1193-6. doi: 10.1007/s00296-009-0840-8. Epub 2009 Jan 20.

Abstract

The purpose of the present study is to investigate the frequency of HLA-B27 and its alleles in reactive arthritis (ReA) and in ankylosing spondylitis (AS) in Tunisia. HLA-B27 alleles were typed by PCR amplification with sequence-specific primers. We studied 17 patients with ReA associated with urethritis or with gastrointestinal infection; 42 HLA-B27-positive patients with AS and 100 healthy controls. Eleven ReA patients (67.7%) were HLA-B27 positive. There was an increased frequencies of HLA-B27 (P = 7.76 x 10(-12), OR = 59.30) and a moderate increase of HLA-B51 (P = 0.015; OR = 4.91) alleles in ReA patients when compared with healthy controls. Four B27 subtypes were identified: B*2702, 05, 09 and B*2712. The distribution of these alleles in the ReA patients was 37.5% for B*2702 and B*2705. Only these two subtypes were detected in 18 (42.8%) and 24 (57.1%), respectively, of the AS patients. B*2709 and B*2712 were relatively rare in ReA patients and were identified in one case each. Our results showed a restricted number of HLA-B27 subtypes associated with ReA and AS. B*2702 and 2705 were common in ReA and AS patients.

MeSH terms

  • Adult
  • Alleles*
  • Arthritis, Reactive / genetics*
  • Arthritis, Reactive / immunology
  • Cross Reactions
  • Cytotoxicity Tests, Immunologic
  • Female
  • Gene Frequency
  • HLA-B27 Antigen / genetics*
  • HLA-B27 Antigen / immunology*
  • Histocompatibility Testing
  • Humans
  • Male
  • Prohibitins
  • Spondylitis, Ankylosing / genetics*
  • Spondylitis, Ankylosing / immunology
  • Tunisia

Substances

  • HLA-B27 Antigen
  • PHB2 protein, human
  • Prohibitins